My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

ABNL vaults as Premji Invest to buy stake in ABCL
Jun 30,2017

The announcement was made after market hours yesterday, 29 June 2017.

Meanwhile, the S&P BSE Sensex was down 137.06 points or 0.44% at 30,720.46

On the BSE, 22,000 shares were traded on the counter so far as against the average daily volumes of 18,200 shares in the past one quarter. The stock hit a high of Rs 1,893 in intraday trade so far, which is a record high for the counter. The stock had hit a low of Rs 1,827 so far during the day. The stock had hit a 52-week low of Rs 1,126.95 on 21 November 2016.

The large-cap company has equity capital of Rs 130.32 crore. Face value per share is Rs 10.

Aditya Birla Capital (ABCL) yesterday, 29 June 2017 entered into a definitive Share Subscription Agreement (SSA) with PI Opportunities Fund - 1 (the Fund), an affiliate of Premji Invest, a private equity fund in India. As per the SSA, the Fund will subscribe to about 2.2% of the post scheme fully diluted equity share capital of ABCL. The proposed transaction values ABCL at Rs 32000 crore on a post money basis, Aditya Birla Nuvo said.

ABCL ranks amongst the top fund managers in India with an aggregate AUM (across asset management, private equity and insurance businesses) of Rs 2.46 lakh crore and a lending book of Rs 38.8 thousand crore as of 31 March 2017.

ABCL has presence across life insurance, asset management, private equity, corporate lending, structured finance, general insurance broking, wealth management, equity, currency and commodity broking, online personal finance management, housing finance, pension fund management and health insurance businesses.

ABCL, formerly known as Aditya Birla Financial Services, is the holding company of the financial services businesses of the Aditya Birla Group. The company had entered into a composite scheme of arrangement (Scheme) with Aditya Birla Nuvo (ABNL) and Grasim Industries (Grasim), basis which the financial services undertaking of Grasim will be transferred to and vested in the company by way of demerger effective from 4 July 2017, following which ABCL shall be listed after obtaining necessary approvals. In accordance with the Scheme, on or prior to 4 July 2017, the company is permitted to issue additional equity shares, to one or more financial investors.

Aditya Birla Nuvos consolidated net profit fell 52.35% to Rs 130.33 crore on 12.47% growth in total income to Rs 4389.34 crore in Q4 March 2017 over Q4 March 2016.

Aditya Birla Nuvo is a business conglomerate. It commands leadership position across its financial services, telecom, linen and manufacturing businesses.

Powered by Capital Market - Live News

Board of Aditya Birla Capital approves preferential issue of equity shares
Jun 30,2017

The Board of Directors of Aditya Birla Capital at its meeting held on 29 June 2017 have approved to offer and issue on preferential issue 4,84,00,000 equity shares of face value of Rs 10 each at a price of Rs 145.40 (including premium of Rs 135.40) to PI Opportunities Fund-1.

The Company announced that pursuant to the Composite Scheme of Arrangement between the Company, Aditya Birla Nuvo and Grasim Industries, the Company is permitted to issue additional equity shares to financial investors aggregating to not more than 5% of the fully diluted share capital of the Company, by way of preferential allotment.

The Company on 29 June 2017 has entered into a definitive Share Subscription Agreement with PI Opportunities Fund - 1, an affiliate of Premji Invest. As per the agreement, the Fund will subscribe to about 2.2% of the post scheme fully diluted equity share capital of the Company. The proposed transaction values the Company at Rs 32000 crore on a post money basis.

Powered by Capital Market - Live News

Biocon to hold board meeting
Jun 30,2017

Biocon will hold a meeting of the Board of Directors of the Company on 27 July 2017.

Powered by Capital Market - Live News

Shree Cement to hold board meeting
Jun 30,2017

Shree Cement will hold a meeting of the Board of Directors of the Company on 31 July 2017.

Powered by Capital Market - Live News

Everlon Synthetics to hold board meeting
Jun 30,2017

Everlon Synthetics will hold a meeting of the Board of Directors of the Company on 4 July 2017.

Powered by Capital Market - Live News

Kirloskar Ferrous Industries to hold board meeting
Jun 30,2017

Kirloskar Ferrous Industries will hold a meeting of the Board of Directors of the Company on 4 July 2017.

Powered by Capital Market - Live News

Glaxosmithkline Pharma to hold board meeting
Jun 30,2017

Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 25 July 2017.

Powered by Capital Market - Live News

GRP to hold AGM
Jun 30,2017

GRP announced that the 43rd Annual General Meeting (AGM) of the company will be held on 10 August 2017.

Powered by Capital Market - Live News

Roselabs Finance to hold board meeting
Jun 30,2017

Roselabs Finance will hold a meeting of the Board of Directors of the Company on 30 June 2017.

Powered by Capital Market - Live News

Cyient to hold board meeting
Jun 30,2017

Cyient will hold a meeting of the Board of Directors of the Company on 13 July 2017.

Powered by Capital Market - Live News

Lyka Labs to hold board meeting
Jun 30,2017

Lyka Labs will hold a meeting of the Board of Directors of the Company on 4 July 2017.

Powered by Capital Market - Live News

Cadila Healthcare gets stronger after USFDA nod for drug
Jun 30,2017

The announcement was made during market hours today, 30 June 2017.

Meanwhile, the S&P BSE Sensex was down 162.07 points, or 0 0.52% to 30,695.86.

On the BSE, 12,589 shares were traded in the counter so far, compared with average daily volumes of 1.54 lakh shares in the past one quarter. The stock had hit a high of Rs 527.35 and a low of Rs 518.80 so far during the day. The stock had hit a record high of Rs 558 on 12 June 2017. The stock had hit a 52-week low of Rs 319.35 on 29 June 2016.

The stock had outperformed the market over the past one month till 29 June 2017, gaining 14.3% compared with 0.81% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 16.61% as against Sensexs 4.49% gains. The scrip had also outperformed the market in past one year, jumping 61.83% as against Sensexs 15.4% gains.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare said that it has received final approval from the United States Food & Drug Administration (USFDA) to market Phentermine Hydrochloride Orally Disintegrating Tablets in strengths of 15mg, 30 mg and 37.5 mg.

The drug is used together with diet and exercise to treat obesity (overweight) in people with risk factors such as high blood pressure, high cholesterol or diabetes and will be produced at the groups formulations manufacturing facility at Moraiya in Ahmedabad.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Indiabulls Real Estate allots NCDs aggregating Rs 500 crore
Jun 30,2017

The Operations Committee of the Board of Directors of Indiabulls Real Estate has allotted NCDs aggregating Rs 500 crore on private placement basis on 29 June 2017.

Powered by Capital Market - Live News

Board of Omansh Enterprises accepts resignation of director
Jun 30,2017

The Board of Omansh Enterprises at its meeting held on 27 June 2017 has taken on record the resignation of Vidya Bhatia, Director from the Board with effect from 29 June 2017.

Powered by Capital Market - Live News

ITC allots 47,82,200 equity shares
Jun 30,2017

ITC has allotted 47,82,200 Ordinary Shares of Re. 1/- each, upon exercise of 4,78,220 Options by Optionees under the Companys Employee Stock Option Schemes on 29 June 2017.

Consequently, the Issued and Subscribed Share Capital of the Company stands increased to Rs. 1215,21,65,271/- divided into 1215,21,65,271 Ordinary Shares of Re. 1/- each.

Powered by Capital Market - Live News